Editorial Expression of Concern: Birinapant Sensitizes Platinum-Resistant Carcinomas With High Levels of cIAP to Carboplatin Therapy
npj Precision Oncology
doi 10.1038/s41698-018-0062-1
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2018
Authors
Publisher
Springer Science and Business Media LLC